The nation of Zimbabwe has declined a major US healthcare agreement worth 367 million US dollars (£272m) over five years due to Washington's request for sensitive biological samples.
This rejection was revealed after a government memo dated December was leaked, indicating that President Emmerson Mnangagwa deemed the agreement was "skewed".
A government spokesperson has since stated that the US was demanding access to genetic material for research and commercial gain but refused to guarantee the benefits from any future treatments.
"We must now begin the challenging and unfortunate process of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.
Her embassy said the United States had furnished more than $1.9bn for health programmes to Zimbabwe during the past two decades.
A physicians' group in Zimbabwe has appealed for further negotiations to reach a agreement acceptable to both sides so the nation's vital HIV programme can continue.
Broader Implications
This development comes after a similar situation in Kenya, where a court blocked a similar deal with the US after legal challenges were filed about the security of citizens' health data.
Since resuming office last year, US President Donald Trump has reduced overseas assistance and shut down the key foreign aid agency.
USAID had overseen assistance for the US government, but Trump claimed its spending was "inefficient" and his administration was pursuing direct bilateral deals to enhance openness and responsibility.
As per reports, Sixteen nations in Africa have to date agreed to similar health pacts, representing over $18.3bn of fresh investment.
Specifics of the Declined Deal
The funds for Zimbabwe was intended to funded "tackling HIV/Aids, tuberculosis, malaria, healthcare for mothers and children, and preparing for epidemics".
"We believe this collaboration might have yielded extraordinary advantages for Zimbabwean communities, particularly the 1.2 million presently receiving HIV treatment through American-funded programmes," Tremont added.
However, government spokesperson Nick Mangwana argued the arrangement was "asymmetrical".
"Zimbabwe was being asked to share its genetic material and health information over an extended period, with no corresponding guarantee of access to any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that might be developed from that shared data," Mangwana explained.
"In essence, our nation would supply the basic resources for medical research without any certainty that the end products would be accessible to our citizens should a future disease outbreak arise."
Sovereignty and Global Health
He also noted that the US's withdrawal from the global health body and its pursuit of one-on-one health agreements were upending frameworks already established via the international organization.
Mangwana cited its Pathogen Access and Benefit Sharing framework designed to manage potential global health emergencies.
"This mechanism is intended to ensure that when a nation provides its information, the benefits – including medicines and cures – are distributed fairly, not monopolised solely by those with the capability to create them."
Zimbabwe's reservations over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We are open to further dialogue with our American counterparts on how future co-operation might be designed in a way that respects the sovereignty and interests of each country."
Medical Community Response
The Zimbabwe College of Public Health Physicians (ZCPHP) said it recognised the official position, but suggested that negotiations should continue given that much of the country's HIV programmes depended on foreign aid.
"Where technical issues arise, such as those relating to data governance or agreement terms, these can often be resolved via detailed discussion and mutually agreed protections," it said.
The situation emphasises the continuing tensions between receiving crucial international aid and safeguarding local interests in an ever more interconnected world.